Sleep Quality and Depression in Patients with Migraine by Boonsongsawat, Supaporn & Teaktong, Thanasak
ไทยเภสชัศาสตรแ์ละวทิยาการสขุภาพ ปี 13 ฉบับ 1, มค. – มคี. 2561  8 Thai Pharm Health Sci J Vol. 13 No. 1, Jan. – Mar. 2018 
 
Sleep Quality and Depression in Patients with Migraine  
 
 
นพินธต์น้ฉบบั   Original Article 
 
   
สภุาภรณ ์บญุสง่สวสัดิ์1 และ ธนศกัดิ ์เทยีกทอง2*  
 
Supaporn Boonsongsawat1* and Thanasak Teaktong2*    
   
1 บัณฑติวทิยาลยั  
2 ภาควชิาเภสชักรรมปฏบิัต ิคณะเภสชัศาสตร ์ 
1-2 มหาวทิยาลยันเรศวร อ.เมอืง จ.พษิณุโลก 65000   
 1 Graduate School  
2 Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences  
1-2 Naresuan University, Phitsanulok, 65000, Thailand 
   
* ตดิตอ่ผูน้พินธ:์ thanasakte@nu.ac.th  * Corresponding author: thanasakte@nu.ac.th 
   
วารสารไทยเภสชัศาสตรแ์ละวทิยาการสุขภาพ 2561;13(1):8-18.  Thai Pharmaceutical and Health Science Journal 2018;13(1):8-18. 
   
 
 
บทคดัยอ่ 
วตัถปุระสงค:์ เพือ่ส ำรวจคุณภำพกำรนอนหลบัและภำวะซมึเศรำ้ในผูป้่วยโรคไม
เกรน และทดสอบควำมสมัพนัธร์ะหวำ่งปจัจยัตำ่ง ๆ กบัคุณภำพกำรนอนหลบัและ
ภำวะซมึเศรำ้ วิธีการศึกษา: กำรวจิยัเชงิพรรณนำแบบภำคตดัขวำงทีศ่กึษำใน
ผูป้่วยโรคไมเกรน 200 รำยทีร่บักำรรกัษำทีแ่ผนกผูป้่วยนอก  โรงพยำบำลเอกชล 
จังหวัดชลบุรี ระหว่ำงวันที่ 26 สิงหำคม ถึง 26 พฤศจิกำยน 2559 โดยใช้
แบบสอบถำมข้อมูลส่วนบุคคล แบบสมัภำษณ์ปจัจยัรบกวนกำรนอนหลบัด้ำน
สิง่แวดล้อม แบบประเมนิคุณภำพกำรนอนหลบัฉบบัภำษำไทย แบบประเมนิ
ควำมเครยีดของโรงพยำบำลสวนปรุง แบบคดักรองภำวะซมึเศรำ้ 2 ค ำถำม (2Q) 
แบบ 9 ค ำถำม (9Q) ของกรมสุขภำพจติ กระทรวงสำธำรณสุข โดยสถติทิีใ่ช้
วเิครำะหข์อ้มลู คอืควำมถีพ่รอ้มรอ้ยละ และคำ่เฉลีย่พรอ้มสว่นเบีย่งเบนมำตรฐำน 
และสถติไิคสแควร์ส ำหรบัทดสอบควำมสมัพนัธ์ระหว่ำงตวัแปรแบบกลุ่ม และค่ำ
สมัประสทิธิส์หสมัพนัธส์เปียรแ์มนส ำหรบัตวัแปรแบบเลขตอ่เนื่อง ผลการศึกษา: 
ผู้ป่วยส่วนมำกมีคุณภำพกำรนอนหลบัที่ไม่ดี (ร้อยละ 78.0) ส่วนมำกมีภำวะ
ซมึเศรำ้ระดบัน้อย (รอ้ยละ 49.0) พบว่ำควำมถี่ของอำกำรปวดศรีษะ ระยะเวลำ
เป็นไมเกรน และรูปแบบกำรสัง่ใช้ยำสมัพนัธ์กับคุณภำพกำรนอนหลบัอย่ำงมี
นัยส ำคญัทำงสถติิที่ระดบั 0.05 ควำมถี่ของอำกำรปวดศีรษะ ระยะเวลำเป็นไม
เกรน และปจัจยักระตุน้อำกำรปวดศรีษะสมัพนัธก์บัภำวะซมึเศรำ้อยำ่งมนีัยส ำคญั
ทำงสถติทิีร่ะดบั 0.05 ควำมเครยีดและปจัจยัรบกวนกำรนอนหลบัดำ้นสิง่แวดลอ้ม
สมัพนัธ์กบัคุณภำพกำรนอนหลบัและภำวะซมึเศร้ำอย่ำงมนีัยส ำคญัทำงสถิตทิี่
ระดบั 0.01 และ 0.05 ตำมล ำดบั ส่วนอำกำรที่เกิดร่วมกับอำกำรปวดศีรษะ 
ประวตัโิรคไมเกรนในครอบครวั ระยะเวลำปวดศรีษะ ระดบัควำมปวดศรีษะโดย
เฉลี่ย กำรดื่มเครื่องดื่มที่มีคำเฟอีน กำรสูบบุหรี่ กำรดื่มเครื่องดื่มที่ผสม
แอลกอฮอล์ไม่สมัพนัธ์กบัคุณภำพกำรนอนหลบัและภำวะซมึเศร้ำ สรปุ: กลุ่ม
ตวัอย่ำงผู้ป่วยโรคไมเกรนส่วนใหญ่มีคุณภำพกำรนอนหลับไม่ดี และมีภำวะ
ซมึเศรำ้ระดบัต ่ำรว่มดว้ย จำกควำมสมัพนัธ์ทีพ่บสำมำรถน ำไปใช้เป็นแนวทำงใน
กำรวำงแผน ดูแล และแก้ไขปญัหำคุณภำพกำรนอนหลบัและภำวะซมึเศร้ำใน
ผูป้่วยโรคไมเกรนตอ่ไป  
ค าส าคญั: ไมเกรน, คุณภำพกำรนอนหลบั, ภำวะซมึเศรำ้   
 
 
Abstract 
Objective: To determine sleep quality and level of depression in migraine 
patients and to examine association between various factors and sleep 
quality and depression. Method: This cross-sectional descriptive study 
recruited 200 migraine patients at the outpatient department of Aikchol 
Hospital, Chonburi, from 26th August to 26th November, 2016. The 
participants were asked to fill the questionnaires for demographic 
information, precipitating factors of sleep disturbance, Thai version of 
Pittsburg Sleep Questionnaire (PSQI), Suanprung Stress Test-20 (SPST-
20), the 2Q and 9Q Depression Screening tests developed by the 
Department of Mental Health, Ministry of Public Health. The data were 
analyzed using frequency with percentage, and mean with standard 
deviation. Chi-square test and Spearman’s rank correlation coefficient were 
used to test associations between categorical and continuous variables, 
respectively. Results: Most patients had a poor sleep (78.0%) and low 
level of depression (49.0%). Frequency of migraine attack, duration since 
migraine diagnosis and pattern of drug prescribing were significantly 
correlated with sleep quality (P-value < 0.05). Frequency of migraine 
attack, duration since migraine diagnosis and stimulating factors of 
headache were significantly correlated with depression (P-value < 0.05). 
Stress and precipitating factors of sleep disturbance were significantly 
correlated with sleep quality and depression (P-value < 0.01 and < 0.05, 
respectively). Comorbidity of migraine, family history of migraine, duration 
of headache, mean score of pain severity, caffeinated beverage intake, 
cigarette smoking, and alcoholic beverage consumption were not correlated 
with sleep quality or depression. Conclusion: Most patients with migraine a 
poor sleep quality and a low depression level. The relationships found 
could be used to plan, manage and resolve sleep quality and depression in 
migraine patients. 
Keywords: migraine, sleep quality, depression   
Introduction 
Migraine is the most common neurological disorder as 
the World Health Organization (WHO) has estimated to be 
as high as 90% of neurological cases.1 With an estimate of 
about 12% of  population worldwide, about 6 million Thais 
suffer from migraine.2 In the US, among persons with severe 
headache, 4 out of 100 had migraine. In Asia, 66% of the 
patients with the headache-related out-patient department 
(OPD) visits had migraine and usually did not receive a 
proper care.1 The annual incidence of migraine is three-fold 
higher in women (18%) than men (6%). In children, it is 
about 4%.3 In women, it occurs most frequently in the age 
range of 24 – 45 years.4  
In a retrospective study at Aikchol Hospital, a private 
hospital in Chonburi province, Thailand, a number of OPD 
prescriptions relating to migraine has increased from 3,646 
prescriptions in 2011 to 5,159 in 2012 and 6,372 in 2013. In 
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these prescriptions, hypnotics, sleep aids such as anxiolytics, 
and analgesics were also given. The most common sleep 
aids included benzodiazepines such as lorazepam and 
diazepam. In 2011, there were 1,753 prescriptions with 
hypnotics and/or sleep-aid drugs which accounted for 
48.08% of all prescriptions for migraine treatment. The 
number of such prescriptions has increased to 2,905 
(56.31%) in 2012 and 4,024 (63.15%) in 2013. Based on 
these findings, such increasing trend is expected over the 
recent years.  
Migraine is a chronic headache with no clear etiology. It 
has been speculated that the excessive constriction and 
dilation of blood vessels in the brain causes a sudden and 
intense headache accompanied with nausea and vomiting, 
and in some cases, blurred vision, and flashing light.  
Migraine not only puts a physical, but also psychological, 
and socio-economical distress on the patient. Their quality of 
life has been negatively affected.2 Negative impact on the 
patients and their family members is inevitable. Work loss, 
decreased activity of daily living and lessened interpersonal 
interaction have been observed. Even though not life-
threatening, migraine is considered by WHO as a chronic 
illness that could cause a disability and should be prevented 
and treated like other chronic diseases.5 In treating migraine, 
its comorbidities should also be identified and managed 
properly.  
Depression is one of the comorbidities of migraine. Patel 
and colleagues found that, among various abnormalities, 
depression was commonly reported both in young adults and 
elderly individuals with an incidence of 28%.6 Since pain 
causes both  physical and psychological distress, the 
patient’s mood is negatively affected. As a result, depression 
has been prevalent among patients with chronic pain. The 
co-existence of pain and depression usually results in a poor 
daily living and a decrease in quality of life. Since about 50% 
of patients with chronic pain also experienced depression, it 
has been known that the two illnesses are highly related.7  
Sleep problem is frequently found among patients with 
headache. More than 50% of migraine patients faced 
difficulty falling a sleep and disrupted sleep. More than 38 of 
migraine patients had less than 6 hours of sleep and more 
than 71% woke up in pain. Since sleeping could alleviate 
migraine headache, 85% of migraine patients need a sleep 
once facing the headache.8 As a basic human need, sleep 
allows for brain rest, restores moods, and nourishes learning 
and memory.9 Abnormal sleep could therefore affect body 
and mind. Negative psychological effects brought by a poor 
sleep could potentially lead to depression.10 Based on  the 
study by Jalilian and co-workers, migraine patients had a 
poorer sleep score when compared with multiple sclerosis 
patients with a statistical signicance.11 They also found that 
sleep score was significantly correlated with depression 
score (P-value < 0.001). It was therefore concluded that 
migraine patients were more likely to experience sleep 
problem and depression.11 Vgontzas, Cui and Merikangas 
studied sleep problem among 80 migraine patients aged 18 
years or older, and found that migraine and sleep problem 
was significantly associated.12 They found that these adult 
patients with migraine encountered a long -term sleep 
problem, difficulty falling asleep, and on-going nightmare. 
Sleep quality is obviously an indicator of sleep problem and 
should be taken seriously for migraine patients.  
With the need to understand sleep problem and 
depression among migraine patients in Thailand, this study 
aimed to determine the extent of sleep problem and 
depression in this group of patients. We also tested the 
association of various factors including environmental sleep 
disturbing factors, treatment regimens and stress, with sleep 
quality and depression. The findings could be used to take 
care of migraine patients with sleep problem and depression. 
It could be also used to prevent depression among these 
patients.  
In this study, sleep quality was defined as perceived 
adequacy of and satisfaction on the sleep of the individuals 
within the last month. Sleep quality included the overall 
quality of the sleep, sleep latency time (minutes), duration of 
sleep (hours), sleep efficiency, sleep disturbance, the use of 
hypnotics or sleep aids, and the impacts of sleep on daily 
activities. Depression was defined as disturbances in affects, 
cognition, motivation and physical status. Symptoms included 
bouts of the blues, negative thoughts, self-blame, 
worthlessness, hopelessness, social isolation, lost interest in 
activities usually enjoyed, suicidal ideation, loss of appetite, 
and insomnia.  
     
Methods 
 
In this descriptive cross-sectional study, sleep quality and 
depression were determined among migraine patients by 
means of a survey. Factors associating with sleep quality 
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and depression were also determined. We studied seven 
factors about migraine headache including duration since 
migraine diagnosis, duration of the headache episode, 
frequency of headache, symptoms accompanying the 
headache, headache triggers, family history of migraine, and 
level of the pain. Another three lifestyle factors were 
caffeinated beverage consumption, cigarette smoking, and 
alcohol intake. We studied stress as a psychological factor. 
In terms of environmental disturbance, sleep disturbing 
factors were also studied. In terms of treatment, migraine 
headache therapy option was investigated. Finally sleep 
quality and depression were determined.  
  A purposive sampling was used to recruit OPD patients 
of Aikchol Hospital, Chonburi, who were diagnosed with 
migraine and followed up during August 26, 2016 to 
November 26, 2016. The sample size was based on the 
formula of Thorndike13, N  10K + 50, where N was the 
desired sample size and K was the number of variables. 
With 15 variables studied, 200 patients were needed. 
The inclusion criteria were as follows. Individuals 
diagnosed with migraine regardless of their gender were 
included. They had to be followed up for their migraine at 
least two visits at the recruitment. The last visit had to be 
less than one month to correspond to the time-frame of 
sleep quality questionnaire. Participants needed to be 20 
years of age or older, and had no celebrovascular disorders, 
hypertension, epilepsy, drug abuse, head or brain injury, 
headaches other than migraine, or other psychological 
illnesses except depression. They were able to communicate 
in Thai and be contacted by phone call.  
 
Data collection instruments  
Five parts of questionnire were used. The first part of 
questionnaire collected demographic information of the 
participants and migraine treatment they received from the 
hospital. This part was created by the researcher and tested 
for content validity by three experts. All questions were 
accepted by all three experts with the perfect average score 
of the content validity index (CVI) of 1. In the second part of 
the questionnaire, environmental sleeping disturbing factors 
were modi f ied f rom  the in terview form of  the sleep 
disturbing factors of Leksawasdi et al.14 Each question asked 
how much each factor disturbed the participant’s sleep with 
a five-level response scale of 1-not at all disturbing, 2-slightly 
disturbing, 3-moderately disturbing, 4-highly disturbing and 5-
extremely disturbing. Based on the three experts, all 
questions had a perfect content validity with CVIs of 1. In 
terms of reliability, the questionnaire had an acceptable 
internal consistency reliability with a Cronbach’s alpha 
coefficient of 0.788.  
The third part of the questionnaire was the Thai version 
of the Pittsburgh Sleep Quality Index (PSQI) which was 
translated into Thai language by Jirapramukpitak and 
Tanchaisawat (1997).15 PSQI had an acceptable internal 
consistency reliability with a Cronbach ’s alpha coefficient of 
0.764. With a possible total score range of 0 – 21 points, a 
total score of 5 or less was defined as a quality sleep while 
a total score of more than 5 indicated a poor sleep quality. 
Based on the time-frame of last month, the questionnaire 
had seven components. In the first component, subjective 
sleep quality, a question evaluated how well the participant 
slept with a response scale of 0 “very well,” to 1 “well,” 2 
“not well,” and 3 “not very well” where a higher score 
indicated a poorer sleep quality. In the second component, 
sleep latency, a question asked how long did it take to fall a 
sleep with a response scale of 0 ‘less than 15 minutes,” to 1 
“16 – 30 minutes,” 2 “31 – 60 minutes,” and 3 “more than 60 
minutes.” Another question asked how often the participant 
had been falling asleep in more than 30 minutes with a 
response scale of 0 “not at all,” to 1 “less than once a week,” 
2 “1 – 2 times per week,” and 3 “3 times per week or 
higher.” The scores from the two questions were summed to 
a possible total score range of 0 to 6. These total score of 0 
point was further categorized as “0,” while 1 – 2 points as 
“1,” 3 – 4 points as “2,” and 5 – 6 points as “3.” It was 
obvious that the higher score indicated a poorer sleep 
quality. In the third component, the nightly sleep hours on 
average was evaluated with a response scale of 0 “more 
than 7 hours,” to 1 “6 – 7 hours,” 2 “5 – 6 hours,” and 3 
“less than 5 hours.” In the fourth component, the participant’s 
answers to the three questions were recalculated as follows. 
The reported number of sleep hours divided by the numbers 
of hours spent in bed (which was calculated from the wake-
up time subtracted by the time going to bed) and multiplied 
by 100%. The resulting % was further categorized as 0 
“more than 85%,” to 1 “75 – 85%,” 2 “65 – 74%,” and 2 “less 
than 65%,” where a higher score indicated a poorer sleep 
quality. In the fifth component, two questions asked the 
participant how often their sleep was disturbed with a 
response scale of 0 “none,” to 1 “less than once a week,” 2 
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“1 – 2 times per week,” and 3 “3 or more per week.” The 
scores of the two questions were summed and further 
categorized as 0 “0 points,” to 1 “1 – 9 points,” 2 “10 – 18 
points,” and 3 “19 – 27 points,” where a higher score 
suggested a poorer sleep quality or more sleep disturbance. 
A single question in the sixth component asked the 
participant how often they used hypnotics or sleep aids with 
a response scale of 0 “never,” to 1 “less than 1 time per 
week,” 2 “1 – 2 times per week,” and 3 “3 times or more per 
week.” In the seventh component, a question asked how 
often the participant were sleepy or falling a sleep while 
performing daily activities with a response scale of 0 “never,” 
to 1 “less than 1 time per week,” 2 “1 – 2 times per week,” 
and 3 “3 times or more per week.” Another question asked 
how much the problem had it been for the participant to 
keep up enthusiasm to get things done with a response 
scale of 0 “not at all,” to 1 “slightly,” 2 “moderately,” and 3 “a 
lot.” Scores of the two questions were summed up and 
further categorized as 0 “0 point” to 1 “1 – 2 points,” 2 “3 – 4 
points,” and 3 “5 – 6 points,” where a higher score indicated 
a more negative impact of sleep problem on the participant’s 
energy.     
The fourth part of the questionnaire evaluated stress 
using the Suanprung Stress Test (1997) which was 
developed by the Department of Mental Health, Ministry of 
Public Health of Thailand.16 With a total of 20 questions, the 
response scale of this questionnaire ranged from 1-not 
stressed at all, to 2-slightly stressed, 3-moderately stressed, 
4-highly stressed and 5-extremely stressed. With a possible 
total score range of 20 – 100 points of stress, a total score 
of 20 – 23 points was categorized as low level of stress, 
while 24 – 41 as moderate, 42 – 61 as high and 62 - 100 as 
extreme level of stress. Suanprung Stress Test had a high 
internal consistency reliability with a Cronbach ’s alpha 
coefficient of 0.848.  
In the fifth part of the questionnaire, the 2Q depression 
sc reen i ng  ques t i onna i re  and  t he  9Q dep re ss i on 
questionnaire developed by the Department of Mental 
Health, Ministry of Public Health, were used.17 Based on the 
2Q depression screening questionnaire, depression was 
preliminarily screened by the two statements : 1) feeling 
down, depressed or hopeless and 2) feeling bored or not 
enjoying things usually enjoyed, within the last two weeks. If 
the answer was “yes” to either or both of the two statements, 
the participant was considered at a certain risk of depression 
and was subject to further evaluation of depression using the 
9Q questionnaire. As suggested by its name, nine questions 
asked the participant how often they felt that way in the last 
two weeks with a response scale of 0-never, to 1-sometimes 
(1 – 7 days). 2-frequent (more than 7 days), and 3-all the 
time (everyday). With a possible total score range of 0 – 27 
points, a total score of 0 – 6 points was further categorized 
as no depression, while 7 – 12 points as a low level of 
depression, 13 – 18 as moderate, and 19 – 27 as severe 
level of depression. This 9Q questionnaire had a high 
internal consistency reliability with a Cronbach’s alpha 
coefficient of 0.917.  
 
Data collection procedure  
This study was approved by the Ethics Committee of 
Faculty of Pharmaceutical Scienceห, Naresuan University 
(approval numbers: 170/59, approval date: August 9, 2016). 
Before data collection was proceeded, the researcher 
provided the potential participants the study objectives and 
asked for their participation. They were assured for 
anynomity and voluntary nature of the participation. Once 
agreeing to participate, they were asked to provide a written 
informed consent. Participants were asked to complete the 
questionnaire by themselves. However, history of migraine 
diagnosis and treatment of the participants were extracted 
from the medical records by the researcher. All data were 
verified and completed before statistical analysis.  
 
Statistical analysis  
Demographic and health s tatus informat ion of the 
participants were presented as frequency with percentage, 
mean with standard deviation, and median with interquartile 
range as appropriate. Quality of sleep and depression were 
tested for association with factors of categorical nature 
including frequency of headache, symptoms accompanying 
the headache, headache triggers, family history of migraine, 
therapy prescribed, and environmental sleep disturbing factor 
by Chi-square tests and contingency coefficients. Factors 
that were continuous variables including duration since 
migraine diagnosis, duration of the headache episode, level 
of the pain, caffeinated beverage consumption (cups per 
day), cigarette smoking (per day), alcohol intake (drinks per 
month), and stress score were tested for associations with 
sleep quality and depression using Spearman’s rank 
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correlation coefficients since these factors were not normally 
distributed.   
  
Results  
 
Among 200 participants, it was found that 47.5% of them 
had the duration since diagnosis of migraine of less than 24 
months with a median of 36 months (interquartile range, or 
IQR, of 60 months). The shortest and longest durations were 
2 months and 20 years, respectively. The majority (51.5%) 
had their headache episode last at hours or less with a 
median of 24 hours (IQR = 28 hours). The shortest and 
longest durations of headache episode were 0.5 hours and 
10 days, respectively. More than three quarters of the 
participants (78.5%) had a frequency of the episode of less 
than 15 days per month. Family history of migraine was 
found in 30.0% of the participants.  
About two-thirds had a pain level of 7 – 9 points (68.5%). 
The most common symptoms accompanying the headache 
were fatigue (84.5%), followed by nausea (67.0%), abnormal 
vision (60.0%) and vomiting (51.0%). Most of these 
symptoms were in moderate severity level . The most 
common triggering factors included somnolence or insomnia 
(75.5%), followed by stress, anxiety, anger or sadness 
(67.5%), and menstruation (35.5%). For physical triggers, the 
extreme hot or cold weather or temperature change was the 
most common trigger (78.0%), followed by staring the bright 
light (54.5%), and unpleasant odor (38.0%). Regarding 
foods, caffeinated beverages (7.0%), followed by red wine or 
alcohol consumption (5.0%), and chocolate (2.0%) were the 
common triggers. In terms of lifestyle, the majority (74.0%) 
drank a cup of coffee daily, did not smoke (94.5%), and 
70.0% had not drunk any alcoholic beverages within the last 
month. For the treatment, slightly more than half of the 
participants were prescribed prophylactic treatments (57.0%) 
while the rest 43.0% were given non -prophylact ic, or 
abortive,  regimens.  
In terms of environmental disturbing factors ,  the 
participants reported their sleep were disturbed by bright 
light, loud noise, and extreme hot or cold weather with the 
moderate level of disturbance. It was found that unpleasant 
odor, uncomfortable bed, roommates, insects and other 
animals did not disturb their sleep.  
 
 
Sleep quality of the participants  
  
More than three quarters of the participants (78.0%) 
reported poor sleep (PSQI total score > 5 points); while the 
rest 22.0% had a quality sleep (Table 1). Among participants 
with poor sleep, the score of sleep latency of 5 – 6 points in 
43.6% of the participants indicated that it took more than 30 
minutes to fall asleep with more than 3 times per week. The 
number of nightly sleeping hours of 6 – 7 hours was found in 
35.9% of those with poor sleep. The majority (76.9%) had a 
low sleep efficiency (> 85%). A total score of sleep 
disturbance of 1 – 9 points in 50.0% of participants with poor 
sleep suggested that they experienced various kinds of 
disturbance such as being awake after 30 minutes of 
bedtime, waking up in the middle of the night, waking up too 
early, waking up to use the restroom, disrupted breathing, 
coughing, snoring, loud noise, feeling too cold or too hot, 
nightmare, and body ache. In terms of the use of hypnotics 
or sleep aids, the majority (66.3%) never used any. A total 
score of the impact on daily activities of 5 – 6 points in 
53.8% indicated the majority were sleepy or falling asleep 
while doing daily activities and less enthusiastic to get things 
done (Table 1).  
Among participants with quality sleep, 97.7% of them 
reported they slept well with a latency time of less than 15 
minutes and no awakening after 30 minutes of the bedtime 
(0 point) in 75.0% (Table 1).  
The majority (65.9%) had more than 7 hours of sleep. 
However, plow sleep efficiency (> 85%) was found in 97.7% 
of them which was higher than those with poor sleep 
(76.9%). Sleep disturbance with score of 1 – 9 points was 
found in 88.7% which was also higher than those with poor 
sleep (50.0%). The majority of participants with quality sleep 
(93.2%) never used hypnotics or sleep aids. It was found 
that 68.2% of them had a score of impact on daily activities 
of 3 – 4 points which suugested that they had less problem 
than those with poor sleep regarding feeling sleepy or falling 
a sleep while doing daily activities or feeling less enthusiastic 
to get things done. 
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 Table 1  Sleep quality of the participants based on seven 
components of PSQI (N = 200).  
 
Component of PSQI 
N (%) by sleep quality 
Having poor sleep 
(n = 156)  
Having quality sleep 
(n = 44) 
Component 1: Subjective sleep quality  
Very well 
Well 
Not well 
Not very well 
0 
44 
94 
18 
0 
28.2 
60.3 
11.5 
0 
43 
1 
0 
0 
97.7 
2.3 
0 
Component 2: Sleep latency (total score of the two questions)  
0  
1 – 2  
3 – 4  
5 - 6 
16 
26 
46 
68 
10.2 
16.7 
29.5 
43.6 
33 
11 
0 
0 
75.0 
25.0 
0 
0 
Component 3: Nightly sleep hours  
> 7 hours  
6 – 7 hours 
5 – 6 hours 
< 5 hours 
51 
56 
39 
10 
32.7 
35.9 
25.0 
6.4 
29 
15 
0 
0 
65.9 
34.1 
0 
0 
Component 4: Sleep efficiency  
> 85% 
75 – 84 % 
65 – 74 % 
< 65% 
120 
31 
5 
0 
76.9 
19.9 
3.2 
0 
43 
1 
0 
0 
97.7 
2.3 
0 
0 
Component 5: Sleep disturbance (total score of the two questions) 
0 
1 – 9 
10 – 18 
19 - 27 
4 
78 
71 
3 
2.6 
50.0 
45.5 
1.9 
2 
39 
3 
0 
4.5 
88.7 
6.8 
0 
Component 6: The use of hypnotics or sleep aids  
Never 
< 1 time per week 
1 – 2 times per week 
3 times of more per week 
103 
2 
37 
14 
66.0 
1.3 
23.7 
9.0 
41 
2 
1 
0 
93.2 
4.5 
2.3 
0 
Component 7: Impact on daily activities (total score of the two questions) 
0 
1 – 2  
3 – 4  
5 - 6 
0 
2 
70 
84 
0 
1.3 
44.9 
53.8 
0 
13 
30 
1 
0 
29.5 
68.2 
2.3 
 
Depression and stress levels of the participants  
In terms of depression, most participants had no and low 
level of depression, 44.0% and 49.0%, respectively (Table 
2). The mean score was 6.91 points. For stress, as high as 
75.0% of participants had high stress level with 13.0% and 
12 .0% w i th  moderate and  ex t reme l eve l  o f  s t r ess , 
respectively. Their mean score of stress was 51.45 points.   
 
 Table 2  Depression and stress levels of the participants (N = 
200).  
 
 N  % 
Depression level (score) by 9Q Depression Questionnaire (mean = 6.91)  
No depression (0 – 6) 
Low (7 – 12)   
Moderate (13 – 18)  
Severe (19 - 27)  
88 
98 
14 
0 
44.0 
49.0 
7.0 
0 
Stress level (score) by Suanprung Stress Test (mean = 51.45) 
Low (20 – 23) 
Moderate (24 – 41)   
High (42 – 61)  
Extreme (62 – 100)  
0 
26 
150 
24 
0 
13.0 
75.0 
12.0 
The associations between categorical variables and sleep 
quality and depression  
It was found that frequency of migraine headache (P-
value = 0.023), treatment regiment (P-value = 0.017) and 
environmental disturbing factor (P-value = 0.005) were 
associated with sleep quality with statistical significance 
(Table 3). For depression, it was fund to signif icantly 
associated with frequency of migraine headache (P-value = 
0.019), having triggers for migraine headache (P-value = 
0.001) and environmental disturbing factor (P-value = 0.005) 
(Table 4).  
 
 Table 3   The associations between categorical variables and 
level of sleep quality (N = 200).  
 
 
N (%) by sleep quality 
 2 
Contingency 
coefficient 
P-
value 
Poor sleep 
(n = 156)  
Quality sleep 
(n = 44)  
Frequency of migraine headache  
< 15 days per month  117 (75.0) 40 (90.9) 5.147 0.158 0.023 
15 days or more per month 39 (25.0) 4 (9.1)    
Having symptoms accompanying the migraine headache  
No 2 (1.3) 2 (4.5) 1.865 0.096 0.172 
Yes 154 (98.7) 42 (95.5)    
Having triggers for migraine headache  
No 1 (0.6) 0 (0) 0.283 0.038 0.594 
Yes 155 (99.4) 44 (100.0)    
Family history of migraine  
No 112 (71.8) 28 (63.6) 1.088 0.074 0.297 
Yes 44 (28.2) 16 (36.4)    
Treatment regimen 
Non-prophylactic 74 (47.4) 12 (27.3) 5.693 0.166 0.017 
Prophylactic  82 (52.6) 32 (72.7)    
Environmental disturbing factor 
No 10 (6.4) 9 (20.5) 7.874 0.195 0.005 
Yes 146 (93.6) 35 (79.5)    
  
 Table 4   The associations between categorical variables and 
level of depression (N = 200).  
 
 N (%) by depression level  
 2 
Contingency 
coefficient P-value 
No 
depression 
(n = 88) 
Low 
depression  
(n = 98) 
Moderate 
depression  
(n = 14) 
Frequency of migraine headache 
< 15 days / month  76 (86.4) 73 (74.5) 8 (57.1) 7.942 0.195 0.019 
15 days or more / month 12 (13.6) 25 (25.5) 6 (42.9)    
Having symptoms accompanying the migraine headache 
No 3 (3.4) 1 (1.0) 0 (0) 1.657 0.091 0.437 
Yes 85 (96.6) 97 (99.0) 14 (100.0)    
Having triggers for migraine headache 
No 0 (0) 0 (0) 1 (7.1) 13.352 0.250 0.001 
Yes 88 (100.0) 98 (100.0) 13 (92.9)    
Family history of migraine 
No 58 (65.9) 70 (71.4) 12 (85.7) 2.443 0.110 0.295 
Yes 30 (34.1) 28 (28.6) 2 (14.3)    
Treatment regimen 
Non-prophylactic 37 (42.0) 41 (41.8) 8 (57.1) 1.229 0.078 0.541 
Prophylactic  51 (58.0) 57 (58.2) 6 (42.9)    
Environmental disturbing factor 
No 15 (17.0) 3 (3.1) 1 (7.1) 10.644 0.225 0.005 
Yes 73 (83.0) 95 (969) 13 (92.9)    
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The associations between continuous variables and 
sleep quality and depression  
Among various continuous variables of participant’s 
demographic characteristics and health status, only duration 
since migraine diagnosis was positively correlated with sleep 
quality score (P-value = 0.016) (Table 5). For mental status, 
stress score was positively correlated with sleep quality (P-
value < 0.001). Similar to the sleep score, depression score 
was found positively correlated with duration since migraine 
diagnosis (P-value = 0.018) and stress (P-value < 0.001) 
(Table 5).  
 
 Table 5   The associations between continuos variables and 
sleep quality score and depression score (N = 200).  
  
Factors  
Sleep quality score Depression score 
* P-value * P-value 
Duration since migraine diagnosis   
Duration of each headache episode   
Average pain level   
Caffeinated beverage intake (cups per day)    
Smoking (cigarettes per day)  
Alcohol intake (drinks per month)  
0.170* 
0.013 
0.017 
-0.108 
-0.065 
0.022 
0.016 
0.852 
0.807 
0.130 
0.360 
0.754 
0.167 
0.012 
0.133 
- 0.017 
0.042 
- 0.058 
0.018 
0.869 
0.061 
0.808 
0.551 
0.411 
     
Stress 0.290 < 0.001 0.522 < 0.001 
    * Spearman’s rho correlation coefficient.  
 
Discussions and Conclusion  
 
Our study found that  majori ty of migraine patient 
participants had a poor sleep (78.0%). This was consistent 
with the study of Sadeghniiat and colleagues which found 
that most migraine patients had poor sleep (PSQI score of 5 
or higher).19 Once each component of PSQI was considered, 
the subject ive sleep quali ty in most part icipants was 
problematic.  In addition, with a sleep latency score of 5 – 6 
points, most participants spent a long time to fall asleep. 
They needed more than 30 minutes to fall asleep. The more 
the latency time, the less the sleep hours. A poor sleep 
could be a result.20 Other sleep disturbance could be due to 
the change in sleep-wake pattern, discomforts, lifestyle 
change, insomniar or somnolence, waking up in the middle 
of the night, waking too early, making a trip to the restroom, 
difficulty breathing, cough, snoring, feeling too hot or too 
cold, nightmare, and body pain.20 Our findings was in line 
with the study of Gori and co-workers revealing that migraine 
patients had a lower sleep wuality and longer sleep latency 
compared with healthy participants.21 These patients also 
face sleep disturbances such as midnight and early waking 
up. Our findings also agreed with the study of Sadeghniiat 
and colleagues reporting that migraine patients had poor 
slep, long sleep latency, taking more than 30 minutes to fall 
asleep, midnight and early waking up, nightmare, body pain, 
hypnotics use, difficulty resuming sleep, and lost interest in 
activities.19 They also found daytime activities were affected 
by consequnces of poor sleep including sleepiness, 
increased daytime napping, loss of energy to work, lethargy, 
fatigue, decreased pain tolerance, depression, irritability, 
indifference, poor decision making, confusion, and increased 
stress.10  
In terms of depression, most participants had a low level 
of depression which was consistent with the study of 
Sadeghniiat et al. reporting that about one out of three 
migraine patients had depression.19 This is because pain is 
highly associated with moods. Those with pain are more 
likely to have a negative affect and mental instability. 
Psychological health issues frequently found include 
depression, insomnia, over anxiety over their illness, 
lethargy, and constant fatigue. The intensity of these mental 
problems is proportional to pain severity, duration of pain, 
and precipitating factors. Depression is a result of these 
mental instabilities.23 The abnormal vascular dilation and 
constriction in migraine could be in part due to the imbalance 
of serotonin24 as a result of various triggers. Stress and 
inadequate sleep could cause a reduced level of serotonin in 
the brain.25 Migraine pain could cause depression with a 
probably similar mechanism. In depression, an over reuptake 
of serotonin back to the post-synaptic neuron leaves a 
deficient amount of serotonin in the synaptic cleft. This 
reduced level of serotonin is believed to cause depressive 
symptoms including feeling or being sad, blues, discouraged, 
bored, unhappy, hopeless, sleepless, waking up in the 
middle of the night, and having frequent nightmare. These 
symptoms affect efficiency of daily activities. In the long run, 
clinical depression is established.26  
Our study found that frequency of migraine headache 
was significantly associated with slep quality and depression 
(P-value < 0.05). This is consistent with the study of 
Sadeghniiat and colleagues reporting that those with more 
monthly episodes of migraine attack had a lower sleep 
quality than those with less frequent episodes, and those 
with 8 days or more per month had a longer sleep latency 
than their counterpart.19 Our finding was in agreement with 
the study of Seidel and colleagues which found that the 
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more frequent the migraine episodes, the less the sleep 
quality, and the longer the sleep latency.27 They revealed 
that poor sleep was found the most prevalent among 
patients with 8 days of headache or more per month, 
followed by those with 5 - 7 days per month, 1 – 4 days per 
month and those with less than 6 days per year, 
respectively.  
In addition, frequent migraine episodes lead to 
depression which was also seen in the study of Seidel et 
al.27 They found that more episodes were associated with a 
higher level of depression as measured by Beck Depression 
Inventory score.27 Specifically, patients with 8 days of 
headache per month had the highest depression level, 
followed by those with 5 – 7 days, 1 – 4 days per month, 
and those with less than 6 days per year, respectively. 
Frequent migraine episodes cause detrimental physical and 
mental well-being. With the cognitive and behavioral 
alteration caused by the frequent pain, the patients are 
continuously obsessed with the repeated pain. Later on their 
moods change and their mental defects such as depression 
are evident.  
Unlike the internal factors of migraine including genetic 
make-up, physiological stress, and hormonal change which 
are unmodifiable, external factors are considered promoting 
factors which could be prevented or avoided. These include 
a lack of sleep, long-hour work, lack of rest, psychological 
stress, alcohol intake, contraceptive medications, and certain 
medications. These factors could alter the balance of 
serotonin which usual ly potent ial lu causes vascular 
vasodilation and constriction in the brain, and that leads to 
migraine headache.18 It has been relatively inconclusive 
about some triggering factors of migraine attack. However,  
based on medical history of migraine patients, some shared 
lifestyles and consumptions are suggestive as triggers of 
migraine.25 The strongest lifestyle and physiological trigger of 
migraine is insomnia and somnolence ,  fol lowed by 
psychological stress, anxiety, anger, depressed mood, and 
mens t rua t i on ,  respec t i ve l y .  The most  i n f l uenc ing 
environmental trigger of migraine is extreme temperature , 
fol lowed by brightl ight and strong odor , respectively. 
Physiologically, insomnia, stress, and extreme temperature 
stimulate the hormonal and/or neurological changes. As a 
result, the biological production of amine substances is 
altered. If the level of serotonin, an amine substance, is 
reduced especially in the brain, migraine could happen. This 
is serotonin controls pain and vascular di lat ion and 
contriction in the brain . Menstruation causes a rise of 
estrogen hormone, insulin and amine substances.25 For 
diets, caffeine in tea and coffee is the most triggering factor 
of migraine, followed by red wine and alcoholic beverages. 
Once the habit of regular caffeine consumption is formed, 
any fluctuation of caffeine intake, either higher or lower than 
usual, could trigger the migraine attack. Red wine and 
alcoholic beverages contain tyramine and flavonoids which 
could also trigger migraine headache. In individual pateints, 
certain triggers such as strong perfume, strong odor, 
brightlight, flickering light, extreme temperature, and certain 
foods should avoided to lessen the frequency of migraine 
attacks.18  
In our study, migraine trigger factors were not associated 
with sleep quality. In terms of distribution of triggers in our 
sample, number of triggers in individual patients ranged from 
zero to as high as seven which was found in one patient. 
Interestingly, patients with no triggers had no sleep problem. 
On the other hand, 44 of those with the triggers had a 
quality sleep. We thus concluded that sleep quality depends 
on many factors other than migraine triggering factors. 
However, we found that migraine triggers were significantly 
associated with depression. This could be due to the fact 
that the patients perceived the triggers as real but 
unavoidable, hence the frustration could lead to the 
subsequent psychological suffering, and the resulting 
depression.  
Treatment of migraine could be classifi ed into non-
prophylax is which is an abort ive t reatment and the 
prophylaxis one to prevent the attack. The non-prophylactic 
treatment is based on various medications including 
ibuprofen, naproxen, diclofenac, meloxicam plus 
paracetamol, etoricoxib plus floctafenine, ibuprofen plus 
ergotamine + caffeine combined formula (eg., Cafergot(R)), 
and etoricoxib plus eletriptan. The goal of non-prophylactic 
treatment is to abort the pain and restore daily living as soon 
as possible.28 For prophylactic treatment, the regimens 
included etoricoxib plus flunarizine, naproxen plus flunarizine 
and amitriptyline, etoricoxib plus floctafenine and 
nortriptyline, etoricoxib plus propranolol, Cafergot® plus 
flunarizine, etoricoxib plus Cafergot® and flunarizine, and 
naproxen plus topiramate. The goal of prophylactic treatment 
is to reduce the frequency, severity and duration of pain 
episodes, and improve effectiveness of the abortive 
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treatment, alleviate headache-related disability or suffering, 
and decrease cost of treatment.29 It was found that treatment 
regimen was significantly associated with sleep quality but 
nnot depression. All treatment regimens usually contain 
analgesics therefore the pain relief could offer the patient a 
better sleep.30 In addition, prophylactic treatments included 
flunarizine, amitriptyline and topiramate, which usually cause 
sedation and drowsiness.18 These treatments hence affected 
the sleep quality. No associated between treatment regimens 
and depression could be due to the fact that most drugs for 
migraine were not related to serotonin level , except for 
Cfergot® and triptan drugs such as eletriptan, and tricyclic 
antidepressants (TCAs) such as amitriptyline and 
nortriptyline. Triptans act on the 5-HT1B and 5-HT1D receptors 
and TCAs on the re-uptake of serotonin and norepinephrine 
to neurons.18,24 Other groups of drugs including NSAIDs, 
paracetamol, flunarizine and topiramate are not related with 
serotonin, therefore the use of these drugs were not 
associated with depression.    
Duration of migraine since diagnosis was significantly 
associated. The longer the duration, the more the discomfort 
and sleep disturbance. Constant pain could cause the 
stimulation of sympathetic nervous system and the secretion 
of cathecholamine, glucagon and cortisol. These sympathetic 
stimulations cause central nervous system excitation and 
hence the insomnia.31 A longer duration of migraine 
therefore leads to poor sleep, poor mental status, and 
suffering. All detrimental effects of migraine could lead to 
depression, and suicidal ideation.23 We also found taht pain 
level was not associated with sleep quality or depression. 
This was different from the study of Sadeghniiat et al. 
revealing that pain intensity score was positively correlated 
with PSQI sleep quality score and depression score as 
measured by Beck Depression Inventory.19 The study by 
Wiriyawong also found a low positive relationship between 
pain level and depression (P-value 0.05).37 Our negative 
finding could be due to the use of numeric rating scale which 
was relied heavily on subjective judgment of individual 
patients. The scale did not correspond well with the actual 
pain level and had a low clinical significance. To determine 
the pain level using this numeric pain scale was therefore 
limited. It could be used in a comparison of pain at different 
time points such as before and during hospital admission 
and at discharge.32  
It was found that stress as measured by Sunprung 
Stress test was associated with sleep quality and depression 
(P-value < 0.01). The use of Suanprung Stress test was 
however a generic measure of stress, not a cause-specific 
one.16 We therefore could not figure out the pain-related 
stress from other causes. Stress is usually correlated with 
sleep quality. The study of Jirapramukpitak and 
Tanchaisawat in healthy nurses found that stress was 
related with poor sleep.15 A study by Wiriyawong also found 
that, in patienst with osteoarthritis, stress was significantly 
correlated with depression.37 Stress is a non-specific 
reponse of the organism to stimuli.33 Illnesses cause physical 
stress which in turn allows sympathetic nervous system to 
act. As a result , more epinephrine, norepinephrine and 
cortisol are released to cause alertness, dilated iris, and 
increased heart rate and blood pressure .34 The stress 
causes loss of appetite, weight loss, lethargy, fatigue, 
discomfort, and insomnia.35 For sleep, stress causes sudden 
wak ing up and d i f f i cu l t y  resuming the s leep ,  and  
subsequent poor sleep.36 Regarding depression, stress 
interferes neurons metabolism leading to a disruption of 
production and degradation of neurotransmitters. Imbalance 
of neurotransmitters results in a decrease in biogenic amines 
especially serotonin which could lead to depresson. A 
decreases in serotonin is associated with a lower positive 
affect. Stress also disrupts neurotransmissions so that the 
decreased sensation, motivatio and appetite, and sleep 
abnormality, decreased concentration, and depression 
eventually.38 To prevent and lessen these stress-related 
problems, there is a need for stress management and 
relaxation technique such as maintaining sleep hygiene and 
regular sleep-wake cycle, meditation, exercise, yoga, 
breathing exercise, and leisure activities of choices. The 
need for pain medications could also be reduced.18 
Envi ronmenta l sleep disturbing t r iggers including 
brightlight, loud noise, extreme temperature, unpleasant 
odor, bedroom discomfort, disturbing roommate, and pests 
and insects were significantly associated with sleep quality at 
a significance level of 0.05. This finding was consistent with 
the study of Rakim and colleagues reporting that 
environmental sleep disturbing factors in the medical wards 
were significantly associated with  sleep quality.39 They 
reported that  the most dis turbing factors was higher 
temperature in the medical ward, noises of the officers, other 
patients, and devices, and constant brightlight.  As in the 
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study of Jauntateero, environmental sleep disturbing factors 
were signfificantly positively associated with sleep quality at 
a significance level of 0.05 with extreme temperature as the 
most disturbing factor, followed by noises. This is also 
consistent with the study of Ramsiri.41 Brightlight affects 
sleep latency time since sleep-wake cycle is controlled by 
darkness and brighness.42 Brightlight inhibits sympathetic 
nervous system and further disrupts the melatonin secretion 
and hence poor and inadequate sleep.43 Noises interfere 
sympathetic nervous system causing the secretion of 
adrenaline. As a result , vascular constriction leads to 
increased diastol ic blood pressure , di lated i ris , and 
contracted muscle. All of these effects wake the person up 
and disrupted and poor sleep is a resul t .44 Extreme 
temperature causes restlessly moving in bed and frequent 
wake up.22 Specifically, the temperature of 29.3 degree 
celcius or higher causes more wake-up and toss-and-turn45 
while a temperature of 12.2 degree celcius or lower causes 
discomfort and disrupted sleep.46 Unpleasant odor irritates 
the person and causes discomfort, difficulty falling a sleep, 
and poor sleep.47 Too hard or too soft beds causes more 
movement while sleeping, less deep sleep, and poor overall 
sleep quality.48 Sleep partners also cause sleep disturbance 
including snoring, moving, talking in the sleep, grinding the 
teeth, and tossing and turning.49 pests and insects could bite 
and cause the release of pain mediated substances 
including bradykinin, antihistamine and substance P. The 
pain signal to the central nervouse system causes pain and 
hence disrupted sleep.50  
In addit ion, our study found environmental sleep 
disturbing factors were signi f icantly associated with 
depression. This was consistent with the study of 
Sadeghniiat et al.19 reporting that sleep quality was positively 
associated with depression (P-value < 0.001). Poor sleep 
could therefore indirectly lead to depression.  
This study has some limitations. Since external factors 
were controlled in this study, their effects, either direct or 
indirect, could not be determined. The study was conducted 
in an OPD of a private hospital, generalizability to a wider 
population is somewhat limited.  
In terms of recommendation, the findings could be used 
in part for planning the care regarding quality sleep for 
migraine patients. Future research should focus on 
management on problems and factors affecting sleep quality 
and depression in migraine patients. Experimental studies 
comparing effectiveness of treatment regimens should be 
conducted. More understanding on factors influencing sleep 
quality and depression among migraine patients should be 
acquired.  
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